215 related articles for article (PubMed ID: 12615292)
1. Mechanisms of plaque stabilization with statins.
Libby P; Aikawa M
Am J Cardiol; 2003 Feb; 91(4A):4B-8B. PubMed ID: 12615292
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of acute coronary syndromes and the potential role of statins.
Dupuis J
Atheroscler Suppl; 2001 Feb; 2(1):9-14. PubMed ID: 11286155
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of statins in acute coronary syndromes.
Foody JM; Nissen SE
Am J Cardiol; 2001 Aug; 88(4A):31F-5F. PubMed ID: 11520485
[TBL] [Abstract][Full Text] [Related]
4. Contribution of the WHHL rabbit, an animal model of familial hypercholesterolemia, to elucidation of the anti-atherosclerotic effects of statins.
Shiomi M; Koike T; Ito T
Atherosclerosis; 2013 Nov; 231(1):39-47. PubMed ID: 24125408
[TBL] [Abstract][Full Text] [Related]
5. [Coronary heart disease prevention. Are there differences in cholesterol synthesis inhibitors?].
Müller-Wieland D; Faust M; Schleifenbaum T; Krone W
MMW Fortschr Med; 2000 Jul; 142(30):26-8. PubMed ID: 10955015
[TBL] [Abstract][Full Text] [Related]
6. Lipid management with statins. The lower the better?
Laufs U; Liao JK; Böhm M
Z Kardiol; 2004 Jan; 93(1):4-9. PubMed ID: 14740235
[TBL] [Abstract][Full Text] [Related]
7. Plaque stabilization: Can we turn theory into evidence?
Libby P; Sasiela W
Am J Cardiol; 2006 Dec; 98(11A):26P-33P. PubMed ID: 17126677
[TBL] [Abstract][Full Text] [Related]
8. [The promise of statins].
Capurso A
Ital Heart J Suppl; 2001 Mar; 2(3):224-9. PubMed ID: 11307780
[TBL] [Abstract][Full Text] [Related]
9. Rationale and design of a randomized clinical study to investigate the effect of ezetimibe, a cholesterol absorption inhibitor, on the regression of intracoronary plaque evaluated by non-obstructive angioscopy and ultrasound: The ZIPANGU study.
Hiro T; Hirayama A; Ueda Y; Komatsu S; Matsuoka H; Takayama T; Ishihara M; Hayashi T; Saito S; Kodama K;
J Cardiol; 2014 Dec; 64(6):501-7. PubMed ID: 24725763
[TBL] [Abstract][Full Text] [Related]
10. Early initiation of statin therapy after a coronary event.
McKeown B; Thompson PL
Curr Opin Lipidol; 2002 Dec; 13(6):631-5. PubMed ID: 12441887
[TBL] [Abstract][Full Text] [Related]
11. HMG-Co A reductase inhibitors in the treatment of cardiovascular diseases: stabilization of coronary artery plaque.
Morishita R; Tomita N; Ogihara T
Curr Drug Targets; 2002 Oct; 3(5):379-85. PubMed ID: 12182229
[TBL] [Abstract][Full Text] [Related]
12. New LDL-cholesterol lowering therapies: pharmacology, clinical trials, and relevance to acute coronary syndromes.
Sahebkar A; Watts GF
Clin Ther; 2013 Aug; 35(8):1082-98. PubMed ID: 23932550
[TBL] [Abstract][Full Text] [Related]
13. Beyond lipids - the role of the endothelium in coronary artery disease.
Aengevaeren WR
Atherosclerosis; 1999 Sep; 147 Suppl 1():S11-6. PubMed ID: 10575057
[TBL] [Abstract][Full Text] [Related]
14. Prevention of stroke and dementia with statins: Effects beyond lipid lowering.
Vaughan CJ
Am J Cardiol; 2003 Feb; 91(4A):23B-29B. PubMed ID: 12615295
[TBL] [Abstract][Full Text] [Related]
15. Statin therapy for elevated hsCRP: what are the public health implications?
Ridker PM
Am J Manag Care; 2010 Aug; 16(8):561-2. PubMed ID: 20712388
[No Abstract] [Full Text] [Related]
16. Effects of statins in reducing thrombotic risk and modulating plaque vulnerability.
Libby P; Aikawa M
Clin Cardiol; 2003 Jan; 26(1 Suppl 1):I11-4. PubMed ID: 12539817
[TBL] [Abstract][Full Text] [Related]
17. The power of statins: aggressive lipid lowering.
Jones PH
Postgrad Med; 2002 Oct; 112(4 Suppl):23-30. PubMed ID: 19667597
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of short-term lipid lowering with ezetimibe and statins on endothelial function in patients with CAD: clinical evidence for 'pleiotropic' functions of statin therapy.
Fichtlscherer S; Schmidt-Lucke C; Bojunga S; Rössig L; Heeschen C; Dimmeler S; Zeiher AM
Eur Heart J; 2006 May; 27(10):1182-90. PubMed ID: 16621868
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of pleiotropic effects of statins: lipid reduction and beyond.
Auer J; Berent R; Weber T; Eber B
Curr Med Chem; 2002 Oct; 9(20):1831-50. PubMed ID: 12369881
[TBL] [Abstract][Full Text] [Related]
20. Intensive reduction of low-density lipoprotein-cholesterol: implications of recent trials.
Hackam DG
Am J Cardiovasc Drugs; 2006; 6(6):367-71. PubMed ID: 17192126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
